Paliperidone Injection–Associated Delayed-Onset Rash

Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.To the Editor: Paliperidone, a benzisoxazole second-generation antipsychotic drug, is the primary active metabolite of risperidone. Paliperidone is indicated for the treatment of patients with schizophrenia and related disorders as a monotherapy and as an adjunct to other pharmacotherapies. Paliperidone exhibits affinity for α1, α2, D2, H1, and 5-HT2A receptors and is thought to improve symptoms by mixed central serotonergic and dopaminergic antagonism.